Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Braskem (BAK) EBT (2016 - 2025)

Braskem has reported EBT over the past 16 years, most recently at -$353.4 million for Q1 2025.

  • For Q1 2025, EBT changed N/A year-over-year to -$353.4 million; the TTM value through Mar 2025 reached $2.7 billion, changed N/A, while the annual FY2025 figure was -$527.7 million, 82.71% up from the prior year.
  • EBT for Q1 2025 was -$353.4 million at Braskem, down from $1.2 billion in the prior quarter.
  • Over five years, EBT peaked at $1.4 billion in Q4 2022 and troughed at -$1.3 billion in Q4 2021.
  • A 4-year average of $372.0 million and a median of $684.2 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: tumbled 424.29% in 2021 and later surged 204.32% in 2022.
  • Year by year, EBT stood at -$1.3 billion in 2021, then surged by 204.32% to $1.4 billion in 2022, then dropped by 14.26% to $1.2 billion in 2023, then crashed by 130.45% to -$353.4 million in 2025.
  • Business Quant data shows EBT for BAK at -$353.4 million in Q1 2025, $1.2 billion in Q4 2023, and $546.5 million in Q3 2023.